← Browse by Condition
Medical Condition

cldn18 2 positive advanced solid tumor

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06350006 Phase 1
Recruiting

SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor

Enrollment
924 pts
Location
China
Sponsor
Shanghai Hengrui Pharmaceutica...
View Trial →